Albert Szent-Györgyi in the United States I.

The potential applications of mRNA technology are wide-ranging: in a few years it could provide a therapeutic strategy for cancer, cardiovascular or autoimmune diseases.

We would like to inform our users that ClinicalKey Student is available on a trial until 7 June 2024.

Calls for application of the Pannonia Scholarship Program have been announced for long- and short-term student mobilities.